These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 18941747)
21. Pharmacokinetics, tissue distribution and anti-tumour efficacy of paclitaxel delivered by polyvinylpyrrolidone solid dispersion. Liu X; Sun J; Chen X; Wang S; Scott H; Zhang X; Zhang Q J Pharm Pharmacol; 2012 Jun; 64(6):775-82. PubMed ID: 22571255 [TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics and neutrophil toxicity of paclitaxel orally administered in mice with recombinant interleukin-2. Jamois C; Comets E; Mentré F; Marion S; Farinotti R; Bonhomme-Faivre L Cancer Chemother Pharmacol; 2005 Jan; 55(1):61-71. PubMed ID: 15378273 [TBL] [Abstract][Full Text] [Related]
23. Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent. Aneja R; Dhiman N; Idnani J; Awasthi A; Arora SK; Chandra R; Joshi HC Cancer Chemother Pharmacol; 2007 Nov; 60(6):831-9. PubMed ID: 17285314 [TBL] [Abstract][Full Text] [Related]
24. [Preparation of paclitaxel-loaded chitosan polymeric micelles and influence of surface charges on their tissue biodistribution in mice]. Huo MR; Zhou JP; Wei Y; Lü L Yao Xue Xue Bao; 2006 Sep; 41(9):867-72. PubMed ID: 17111835 [TBL] [Abstract][Full Text] [Related]
25. Cremophor-free intravenous microemulsions for paclitaxel II. Stability, in vitro release and pharmacokinetics. Nornoo AO; Chow DS Int J Pharm; 2008 Feb; 349(1-2):117-23. PubMed ID: 17869458 [TBL] [Abstract][Full Text] [Related]
26. [Pharmacokinetics of paclitaxel in experimental animals. Part 1. Blood level]. Fujita H; Okamoto M; Takao A; Mase H; Kojima H Gan To Kagaku Ryoho; 1994 Apr; 21(5):653-8. PubMed ID: 7908791 [TBL] [Abstract][Full Text] [Related]
27. Enhanced paclitaxel bioavailability after oral administration of pegylated paclitaxel prodrug for oral delivery in rats. Choi JS; Jo BW Int J Pharm; 2004 Aug; 280(1-2):221-7. PubMed ID: 15265561 [TBL] [Abstract][Full Text] [Related]
28. The influence of the P-glycoprotein inhibitor zosuquidar trihydrochloride (LY335979) on the brain penetration of paclitaxel in mice. Kemper EM; Cleypool C; Boogerd W; Beijnen JH; van Tellingen O Cancer Chemother Pharmacol; 2004 Feb; 53(2):173-8. PubMed ID: 14605863 [TBL] [Abstract][Full Text] [Related]
29. Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients. Malingré MM; Beijnen JH; Rosing H; Koopman FJ; Jewell RC; Paul EM; Ten Bokkel Huinink WW; Schellens JH Br J Cancer; 2001 Jan; 84(1):42-7. PubMed ID: 11139311 [TBL] [Abstract][Full Text] [Related]
30. Different tissue distribution of paclitaxel with intravenous and intraperitoneal administration. Soma D; Kitayama J; Ishigami H; Kaisaki S; Nagawa H J Surg Res; 2009 Jul; 155(1):142-6. PubMed ID: 19328496 [TBL] [Abstract][Full Text] [Related]
31. Enhancement of oral bioavailability of paclitaxel after oral administration of Schisandrol B in rats. Jin J; Bi H; Hu J; Zhong G; Zhao L; Huang Z; Huang M Biopharm Drug Dispos; 2010 May; 31(4):264-8. PubMed ID: 20437465 [TBL] [Abstract][Full Text] [Related]
32. Docetaxel: pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat model. Marchettini P; Stuart OA; Mohamed F; Yoo D; Sugarbaker PH Cancer Chemother Pharmacol; 2002 Jun; 49(6):499-503. PubMed ID: 12107555 [TBL] [Abstract][Full Text] [Related]
33. PEG conjugated N-octyl-O-sulfate chitosan micelles for delivery of paclitaxel: in vitro characterization and in vivo evaluation. Qu G; Yao Z; Zhang C; Wu X; Ping Q Eur J Pharm Sci; 2009 May; 37(2):98-105. PubMed ID: 19429416 [TBL] [Abstract][Full Text] [Related]
34. Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patients. Bulitta JB; Zhao P; Arnold RD; Kessler DR; Daifuku R; Pratt J; Luciano G; Hanauske AR; Gelderblom H; Awada A; Jusko WJ Cancer Chemother Pharmacol; 2009 May; 63(6):1049-63. PubMed ID: 18791718 [TBL] [Abstract][Full Text] [Related]
35. Stabilized micelles as delivery vehicles for paclitaxel. Yoncheva K; Calleja P; Agüeros M; Petrov P; Miladinova I; Tsvetanov C; Irache JM Int J Pharm; 2012 Oct; 436(1-2):258-64. PubMed ID: 22721848 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics and tissue distribution of intraperitoneal paclitaxel with different carrier solutions. Mohamed F; Marchettini P; Stuart OA; Sugarbaker PH Cancer Chemother Pharmacol; 2003 Nov; 52(5):405-10. PubMed ID: 12879282 [TBL] [Abstract][Full Text] [Related]
37. Biodistribution of paclitaxel and poly(L-glutamic acid)-paclitaxel conjugate in mice with ovarian OCa-1 tumor. Li C; Newman RA; Wu QP; Ke S; Chen W; Hutto T; Kan Z; Brannan MD; Charnsangavej C; Wallace S Cancer Chemother Pharmacol; 2000; 46(5):416-22. PubMed ID: 11127947 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and biodistribution of paclitaxel loaded in pegylated solid lipid nanoparticles after intravenous administration. Li R; Eun JS; Lee MK Arch Pharm Res; 2011 Feb; 34(2):331-7. PubMed ID: 21380818 [TBL] [Abstract][Full Text] [Related]
39. Translymphatic chemotherapy by intrapleural placement of gelatin sponge containing biodegradable Paclitaxel colloids controls lymphatic metastasis in lung cancer. Liu J; Meisner D; Kwong E; Wu XY; Johnston MR Cancer Res; 2009 Feb; 69(3):1174-81. PubMed ID: 19176391 [TBL] [Abstract][Full Text] [Related]
40. Comparison of pharmacokinetic and metabolic profiling among gossypol, apogossypol and apogossypol hexaacetate. Jia L; Coward LC; Kerstner-Wood CD; Cork RL; Gorman GS; Noker PE; Kitada S; Pellecchia M; Reed JC Cancer Chemother Pharmacol; 2008 Jan; 61(1):63-73. PubMed ID: 17356822 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]